LACTULOSE FRESENIUS 670 mg/ml, oral solution in a vial 10 bottles of 200 ml
Active ingredients: Β-lactulose, LACTULOSE LIQUIDE
Commercialized according to BDPM
Oral solution10 bottles of 200 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LACTULOSE FRESENIUS 670 mg/ml, solution buvable en flacon
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 10 flacon(s) polytéréphtalate (PET) brun de 200 ml avec gobelet(s) doseur(s) polypropylène
- Marketing authorisation holder
- FRESENIUS KABI AUSTRIA (AUTRICHE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 9 Mar 2022
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69828759CIP74969436CIP133400949694365Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LACTULOSEsolution | 670 mg · 1 ml | FT |
| LACTULOSE LIQUIDEsolution | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.